Keywords: CHP; Chronic hypersensitive pneumonia; DILD; Drug-induced interstitial lung disease; IIP; Idiopathic interstitial pneumonia; ILD; Interstitial lung disease; IPF; Idiopathic pulmonary fibrosis; PCV13; 13-valent pneumococcal conjugated vaccine; PPSV23; 23-v
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: pneumococcal conjugate vaccine; pneumococcal polysaccharide vaccine; immunization information system; sickle cell disease; ACIP; Advisory Committee on Immunization Practices; LBF; Live birth file; MCIR; Michigan Care Improvement Registry; MCV4; 4-Valent m
Keywords: Community pharmacy; Pharmacist; Immunization; Vaccine; IIS; Immunization Information Systems; ACIP; Advisory Committee on Immunization Practices; APhA; American Pharmacists Association; CDC; Centers for Disease Control and Prevention; CMS; Centers for Med
Keywords: PPSV23; 23-valent pneumococcal polysaccharide vaccine; PCV13; 13-valent pneumococcal conjugate vaccine; influenzavaccine; seasonal influenza vaccine; COPD; chronic obstructive pulmonary disease; ADL; activities of daily living; OR; odds ratio; CI; confide
Keywords: Streptococcus pneumoniae; Vaccine; PCV13; PPSV23; Serotype replacement;
Keywords: ACIP; Advisory Committee on Immunization Practices; CAPiTA; Community-Acquired Pneumonia Immunization Trial in Adults; CPS; capsular polysaccharide; IPD; invasive pneumococcal disease; NIPP; noninvasive pneumococcal pneumonia; PCV7; 7-valent pneumococcal
Keywords: Idiopathic nephrotic syndrome (NS); Immunization; Streptococcus pneumoniae; 13-valent pneumococcal conjugate vaccine (PCV13); Vaccine; Enzyme-linked immunosorbent assay (ELISA); AIM; alternative immunosuppressive medication; CI; confidence interval; ELISA
Keywords: Cost-effectiveness analysis; PPSV23; Pneumococcal disease; Vaccine;
Keywords: AE; adverse event; CAP; community-acquired pneumonia; GMFR; geometric mean fold rise; GMT; geometric mean titer; IPD; invasive pneumococcal disease; OPA; opsonophagocytic activity; PCV13; 13-valent pneumococcal conjugate vaccine; PPSV23; 23-valent pneumoc
Keywords: AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; IPD; invasive pneumococcal disease; LLOQ; lower limit of quantitation; LOD; limit of detection; OPA; opsonophagocytic ac
Keywords: ACIP; United States Advisory Committee on Immunization Practices; AE; adverse event; CI; confidence interval; CRM197; cross-reactive material 197; GMR; geometric mean ratio; GMT; geometric mean titer; OPA; opsonophagocytic activity; PCV; pneumococcal poly
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults â¥50â¯years of age: A randomized trial
Keywords: VZV; varicella-zoster virus; HZ; herpes zoster; PHN; postherpetic neuralgia; CDC; United States Centers for Disease Control and Prevention; YOA; years of age; ZVL; zoster vaccine live; RZV; adjuvanted recombinant zoster vaccine; PPSV23; 23-valent pneumoco
Functional immune responses to 11 non-PCV13 serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults
Keywords: PPSV23; 23-valent pneumococcal polysaccharide vaccine; IPD; invasive pneumococcal diseases; PCV13; 13-valent pneumococcal conjugate vaccine; OPA; opsonophagocytic assay; MOPA; multiplexed OPA; OBB; opsonization buffer B; BRC; Baby rabbit complement; THY;
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2-17-year-old children with asplenia or splenic dysfunction: A phase 3 study
Keywords: Pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV); Immunogenicity; Safety; Asplenia; Splenic dysfunction; AE; adverse event; ATP; according-to-protocol; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay
Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults
Keywords: aIIV3; adjuvanted trivalent inactivated influenza vaccine; IIV3; inactivated trivalent influenza vaccine; PPSV23; 23-valent pneumococcal polysaccharide vaccine; PCV13; 13-valent pneumococcal conjugate vaccine; HI; hemagglutination inhibition; GMT; geometr